Remote Programming of Cardiac Implantable Electronic Device
REACT
1 other identifier
interventional
110
1 country
1
Brief Summary
Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators, need to be regularly interrogated and reprogrammed to ensure proper functioning. While remote monitoring allows for partial interrogation at a remote location, full interrogation and changing the CIED parameters is only possible when the patient visits a cardiologist capable of performing device programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. We aim to investigate the efficacy and safety of remote programming.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2022
CompletedFirst Submitted
Initial submission to the registry
May 5, 2022
CompletedFirst Posted
Study publicly available on registry
May 9, 2022
CompletedJune 17, 2025
June 1, 2025
10 months
May 5, 2022
June 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful remote interrogation and programming of CIED
Success rate of remote interrogation and programming of CIED
18 months
Secondary Outcomes (4)
To assess the user-friendliness of the system (1)
18 months
To assess the user-friendliness of the system (2)
18 months
To assess the user-friendliness of the system (3)
18 months
To assess the user-friendliness of the system (4)
18 months
Study Arms (1)
CIED's interrogation/programming
EXPERIMENTALAll the patients will be included in this single arm to interrogate/programm their CIED
Interventions
As the study investigates remote programming, we will describe two locations: local (patient side) and remote (expert side). Local support is defined by a physician or a technician under the direct responsibility of a nearby physician who connect the patient to the remote programming system. Similar to a conventional check-up, an external defibrillator will be located in the near vicinity of the patient. The patient will first be connected to the programmer as during a conventional follow-up. The programmer will then be connected to a local PC which captures the programmer VGA video output and controls the programmer through a mouse emulator. This local PC will be remotely controlled by the remote PC using Cisco Webex, a communication software used worldwide to support telemedicine.
Eligibility Criteria
You may qualify if:
- Patient of both sexes over the age of 18
- Patients implanted with a cardiac pacemaker or an automatic defibrillator and an indication for device check-up (interrogation ± programming) which may be periodic as part of their follow-up, postoperative, following a remote monitoring alert, pre/post MRI or following symptoms.
- Person beneficiary of social security insurance.
- Women of procreating age with effective contraception
You may not qualify if:
- Patients younger than 18 years old
- Patients who are incapable to understand the study design or to give informed consent.
- Pregnant or breastfeeding women
- Persons placed under judicial protection, curatorship, tutorship.
- Subject deprived of liberty on judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bordeaux University Hospital
Pessac, France, 33604, France
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvain MD Ploux
University Hospital, Bordeaux
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2022
First Posted
May 9, 2022
Study Start
June 8, 2021
Primary Completion
April 4, 2022
Study Completion
April 4, 2022
Last Updated
June 17, 2025
Record last verified: 2025-06